NCBI on safety study of meloxicam

Dose response and safety study of meloxicam up to 22.5 mg daily in rheumatoid arthritis: a 12 week multicenter, double blind, dose response study versus placebo and diclofenac. Furst DE1, Kolba KS, Fleischmann R, Silverfield J, Greenwald M, Roth S,...

Read More

1 Al-Mosher Ahmed Ismail St. Heliopolis, Cairo, Egypt Sheraton 2nd Floor, No. 44

Call Us Now at

Call Us Now at

(202) 22685092

Email Us at

Email Us at

info@polypharm-eg.com

PolyPharm

PolyPharm

About Us